Author: Zacks Small Cap Research

123454130 / 408 POSTS
By Steven Ralston, CFATSX:WML.V | OTC:WMLLFREAD THE FULL WML.V RESEARCH REPORTWealth Minerals (TSX:WML.V) (OTC:WMLLF) is a junior mineral exploration company that is well-positioned to benefit from its portfolio of prospective lithium projects in the ...
By John Vandermosten, CFANASDAQ:TENXREAD THE LATEST TENX RESEARCH REPORT2018 Financial and Operational ReviewDuring 2018 Tenax Therapeutics, Inc. (NASDAQ:TENX) re-aligned the company towards the development of levosimendan for Pulmonary Hypertension ...
By John Vandermosten, CFANASDAQ:AZRXREAD THE LATEST AZRX RESEARCH REPORTOn April 1st, AzurRx BioPharma, Inc. (NASDAQ:AZRX) filed its 2018 10-K with the SEC for the twelve month period ending December 31, 2018. Highlights for the year and to date incl ...
By John Vandermosten, CFANASDAQ:TTNPREAD THE LATEST TTNP RESEARCH REPORTFull Year 2018 Financial and Operational ResultsTitan Pharmaceuticals, Inc. (NASDAQ:TTNP) reported full year 2018 results in an April 1st press release and in a subsequently file ...
By John Vandermosten, CFANASDAQ:HTBXREAD THE LATEST HTBX RESEARCH REPORTFull Year 2018 ResultsHeat Biologics, Inc. (NASDAQ:HTBX) reported full year 2018 results in a March 28 release and concurrently submitted the companion 10-K to the SEC. Heat atte ...
By Ian Gilson, PhD, CFANASDAQ:MBIIREAD THE FULL MBII RESEARCH REPORTMarrone Bio Innovations (NASDAQ:MBII) has announced that Regalia Maxx has received label approval from Canada's Pest Management Regulatory Agency for use on marijuana (Canadian: mari ...
By David Bautz, PhDNASDAQ:TNXPREAD THE FULL TNXP RESEARCH REPORTBusiness UpdatePhase 3 RECOVERY Trial UnderwayOn March 11, 2019, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced the first patient has been enrolled in the RECOVERY Phase 3 s ...
By John Vandermosten, CFATSX:RVX.TOREAD THE LATEST RVX RESEARCH REPORTThird Quarter 2019 ResultsResverlogix Corp (TSX:RVX.TO) provided an update of the financial and operational results for the period of November 1, 2018 to January 31, 2019. During t ...
By John Vandermosten, CFAOTC:DYAIREAD THE LATEST DYAI RESEARCH REPORTFiscal Year 2018 Dyadic International Inc. (OTC:DYAI) released full year 2018 financial and operational results on March 27, 2019. Revenues were $1.3 million and represented researc ...
By Beth Senko, CFAOTC:INNV | OTC:INNVDREAD THE FULL INNV RESEARCH REPORTInnovus Pharma (OTC:INNV) (OTC:INNVD) announced 4Q18 and full year results on April 1, 2019. To us, results signaled a change in corporate priorities, with the Company focused on ...
123454130 / 408 POSTS